2001
DOI: 10.1161/01.str.32.7.1613
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective Effect of σ 1 -Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production

Abstract: Background and Purpose-The potent 1 -receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) provides neuroprotection in experimental stroke. We tested the hypothesis that PPBP attenuates striatal tissue damage after middle cerebral artery occlusion (MCAO) by a mechanism involving reduction of ischemia-evoked nitric oxide (NO) production. Furthermore, we determined whether the agent fails to protect ischemic brain when neuronal nitric oxide synthase (nNOS) is genetically deleted or pharmacologically inhib… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
68
0

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 76 publications
(69 citation statements)
references
References 53 publications
1
68
0
Order By: Relevance
“…σR1 ligands have broad neuroprotective effects. They not only reduce NMDA receptor activation [5,34], but also can inhibit ischemia-induced glutamate release [27,28], attenuate postsynaptic glutamate-evoked Ca 2+ influx [10,20], and reduce NO production [14]. These beneficial effects of σR1 ligands are noteworthy for diseases in which ganglion cells die, such as in glaucoma [24,25] and, as has been reported recently, in diabetic retinopathy [2,12,15,55].…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…σR1 ligands have broad neuroprotective effects. They not only reduce NMDA receptor activation [5,34], but also can inhibit ischemia-induced glutamate release [27,28], attenuate postsynaptic glutamate-evoked Ca 2+ influx [10,20], and reduce NO production [14]. These beneficial effects of σR1 ligands are noteworthy for diseases in which ganglion cells die, such as in glaucoma [24,25] and, as has been reported recently, in diabetic retinopathy [2,12,15,55].…”
Section: Discussionmentioning
confidence: 84%
“…The neuroprotective effects of σR1 ligands are thought to include modulation of NMDA receptors as well as muscarinic receptors [5,35]. Sigma receptor ligands demonstrate robust neuroprotective properties including inhibition of ischemia-induced glutamate release [27,28], attenuation of postsynaptic glutamate-evoked calcium influx [10,20], depressed neuronal responsivity to NMDA receptor stimulation [3,7,54], and reduced NO production [14].…”
Section: Introductionmentioning
confidence: 99%
“…7NI and PJ-34 are among the most specific inhibitors available for nNOS and PARP, respectively, and both greatly exacerbate ischemic damage selectively in females. Doses administered in the study were based on efficacy in previous experiments in males, and we did not examine a full range of doses in these experiments (Goyagi et al, 2001;Abdelkarim et al, 2001;Coert et al, 1999). While it is possible that pharmacokinetics for these agents differ by sex, it seems unlikely that such a factor could explain the combined and perfectly consistent observations in knockouts and drug-treated cohorts.…”
Section: Discussionmentioning
confidence: 99%
“…Ten ␣-Syn Ϫ/Ϫ mice and 10 WT mice with body weights of 27-32 g were anesthetized with 1-1.2% halothane in oxygen-enriched air, and rectal temperatures were controlled at 37 Ϯ 0.5°C with heating lamps during the entire surgical procedure. Mice were then subjected to unilateral middle cerebral artery occlusion in a randomized fashion (7)(8)(9). In brief, a 5-0 nylon monofilament was inserted via an external carotid artery stump to a point 6-mm distal to the internal carotid artery͞pterygopalatine bifurcation, and the common carotid was temporarily occluded with a 6-0 nylon suture.…”
Section: Methodsmentioning
confidence: 99%